Barclays Reiterates Overweight Rating on Constellation Brands Shares Despite Stock Underperformance By Investing.com
On Friday, Barclays changed their price target on shares of Constellation Brands (NYSE: ), the leading liquor company. The target price was revised to $300.00 from the previous target of $309.00. Despite this change, Barclays has maintained an Overweight rating on the company's stock.
The restructuring follows the company's recent issuance, which Barclays believes also reflects Constellation Brands' successful transition “from builder to operator.” This change is seen as a key factor contributing to the company's continued superior performance in the beer segment and the realization of significant cost savings within the organization.
According to the analyst's statement, the stock's recent underperformance could be attributed to the market's skepticism about the expected increase in contraction throughout the remainder of the 2025 fiscal year. Investors may interpret that Constellation Brands is unlikely to lower its financial projections, contrary to expectations. .
Despite these concerns, Barclays remains confident in the company's prospects, especially in the growth of net sales of beer, which is expected to remain at around +6%. The company also positioned itself near the middle of Constellation Brands' earnings per share (EPS), which ranged from $13.60 to $13.80, with an EPS estimate of $13.66.
In other recent news, Constellation Brands has seen a mixed bag of developments. The company's second quarter results showed a nearly 6% increase in net sales and a 13% increase in operating income in the beer business. Despite the decline in Corona Extra sales, management remains optimistic about the product's performance for the remainder of the year. Other beer brands such as Modelo Especial and Pacifico showed positive trends, contributing to the overall strength of the beer segment.
Several firms have adjusted their views on Constellation Brands. HSBC cut its price to $285, and Jeffery's cut theirs to $309, both citing challenges in the beer category. Truist Securities also revised its sales and earnings per share estimates for the company, resulting in a drop in its stock price to $255.00. However, they, along with Roth/MKM, Evercore ISI, and Goldman Sachs, maintained their Buy or Outperform ratings, expressing confidence in the company's growth.
Roth/MKM expects strong beer shipments to propel the company toward its FY25 guidance. Evercore ISI decreased their target price from $310.00 to $300.00, while Goldman Sachs maintained their price target at $300.
InvestingPro Insights
To complement Barclays' analysis of Constellation Brands (NYSE:STZ), recent data from InvestingPro provides additional context. The company's market capitalization reaches $44.77 billion, indicating its significant presence in the alcohol industry. Constellation Brands has shown consistent profitability, with InvestingPro data showing that the company has been profitable for the past twelve months.
One of InvestingPro's tips highlights that Constellation Brands has raised its dividend for 10 consecutive years, which may be attractive to income-oriented investors. This dividend growth, coupled with a current dividend yield of 1.66%, underscores the company's commitment to shareholder returns.
Another good InvestingPro tip shows that Constellation Brands' liquid assets exceed its short-term liabilities, suggesting a strong financial position. This is in line with Barclays' confidence in the company's operational transformation and cost savings plans.
For investors looking for a more comprehensive analysis, InvestingPro offers 5 additional tips that can provide additional insight into Constellation Brands' financial health and market conditions.
Article enriched by InvestingPro Insights
This article was created with the support of AI and reviewed by an editor. For more information see our T&C.
